Our work focuses on identifying policy-relevant strategies to reduce the burden of vaccine-preventable respiratory diseases in the United States and globally. We do this by using a unique combination of cutting-edge quantitative analysis, experimental tools, and community-based sampling. This combination of approaches allows us to bring novel insights about how to maximize the impacts of public health interventions. Learn more about the work in the Weinberger Lab here.
I focus on identifying policy-relevant strategies to reduce the burden of vaccine-preventable respiratory diseases by using a unique combination of cutting-edge quantitative analysis, experimental tools, and community-based sampling. I use this unique combination of tools to understand the impact of existing interventions and to guide the development of more effective approaches. My work has received international exposure at meetings of the WHO and PAHO, and I have provided technical consultations based on my work to the CDC, WHO, GAVI The Vaccine Alliance, and numerous vaccine manufacturers (Pfizer, Merck, GSK, Affinivax, Matrivax). The lab has been supported by a diverse grant portfolio that includes funding from the NIH, the Bill and Melinda Gates Foundation, Pfizer, Merck, the Department of Veterans Affairs, and the Connecticut Emerging Infection Program. My work has focused largely on understanding the impacts of vaccines (against pneumococcus HPV, RSV), on developing improved vaccination strategies for children and adults, and on developing novel quantitative methods to evaluate the impact of public health interventions. This research employs a variety of methods including statistical and dynamic modeling, experimental microbiology, and bioinformatics. More recently, we have started performing field studies to understand the transmission dynamics of respiratory pathogens among adults in the US.
Americas; Bacterial Infections; Biology; Carrier State; Communicable Disease Control; Denmark; Epidemiologic Methods; Europe; Fourier Analysis; Iceland; Influenza, Human; Netherlands; Population Characteristics; Public Health; Respiratory Tract Infections; Streptococcus pneumoniae; Biostatistics; Diseases
Aging; Emerging Infectious Diseases; Genetics, Genomics, Epigenetics; Global Health; Infectious Diseases; Influenza; Maternal & Child Health; Microbial Ecology; Modeling; Respiratory Disease/Infections; Child/Adolescent Health; COVID-19